Christos Lazari Foundation takes 4.8% stake in Anastasis Biotec
Published
Christos Lazari Foundation has joined the register of Anastasis Biotec, a biotechnology cancer therapeutics firm, with 169,680 ordinary shares. The overall issued share count increased during the period, and this is the only non-individual entry or exit shown in the supplied filing. The filing was made on 7 November 2025, covering the period from 7 November 2024 to 7 November 2025.
Shareholder data
Source: Companies House confirmation statement (CS01) — period to , filed .
Changes in this confirmation statement
| Type | Shareholder | Shares | Change | Share classes |
|---|---|---|---|---|
| New shareholder | CHRISTOS LAZARI FOUNDATION | 169,680 | — | ORDINARY 169,680 |
| New shareholder | MILUNIT AB | 1,000 | — | ORDINARY 1,000 |
Current shareholders (5)
| Shareholder | Total shares | Share classes |
|---|---|---|
| CHRISTOS LAZARI FOUNDATION | 169,680 | ORDINARY 169,680 |
| CROWDCUBE NOMINEES LIMITED | 80,018 | ORDINARY 80,018 |
| BEMMS PROPERTY LTD | 3,100 | ORDINARY 3,100 |
| MILUNIT AB | 1,000 | ORDINARY 1,000 |
| AET AD/VENTURES LTD, REGISTRATION NUMBER 40003853153 | 174 | ORDINARY 174 |
Contact the editorial team at editorial@fundingspotter.com